Moscow. December 25. Co-owner of Moscow credit Bank Roman Avdeev has closed a deal to purchase a controlling package pharmacy group A5 (brands “A5”, “Standard” and “Formador”).
As reported by Roman Buzdalin, which along with Sergey Malt belonged to 68,75% A5, he and his partner came out of the pharmaceutical company, sold its stake of OOO “Concern “Rossium” (owns assets Avdeeva, including 70,02% ICD).
The buzdalin refused to name the amount of the transaction.
A week earlier it became known that Avdeev acquires controlling stake in A5 pharmacy, buying share Buzdalin and Solodov. The second shareholder A5 – Fund Baring Vostok Private Equity Fund V (31,25%) – will retain its stake in the company.
In the future, the banker plans to merge with A5 “Pharmacy chain 36.6”.
At the end of 2014 A5 totaled 1,005 thousand pharmacies. In 2015, the company’s management planned to increase its network by 28% to 1,285 thousand points. A5 revenue by the end of 2014 amounted to 26 billion rubles, an increase of 27%. In 2015 this figure was expected to grow by 42% to 36.9 billion rubles.
The merger with A5 will become the first M&A transaction for “Pharmacy chain 36,6”. At the end of September of the current year the company completed the merger with the A. V. Group e, which was carried out in the framework of the additional issue. The structure of the majority shareholders “36,6” Vladimir Kintsurashvili and Ivan Saganelidze Palesora Limited contributed as payment of shares 100% of shares of operating companies – LLC “Apteka-A. V. e” and LLC “Apteka-A. V. e-1”. As a result, the pharmacy chain A. V. e became part of the group of companies “36,6”, and the proportion rose to Palesora of 78.96%.
A. v.e Group and “36,6” developing brands “pharmacy chain 36.6”, “Gorzdrav”, A. v.e, “Old doctor”. At the end of June 2015 under the management of the group was 780 pharmacies. The group’s revenue in the first half of this year amounted to $ 16,101 billion.